Form 8-K - Current report:
SEC Accession No. 0001628280-25-011830
Filing Date
2025-03-11
Accepted
2025-03-11 07:40:24
Documents
15
Period of Report
2025-03-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bvs-20250311.htm   iXBRL 8-K 32776
2 EX-99.1 bioventusex-991q42024.htm EX-99.1 514708
6 image_0.jpg GRAPHIC 50612
  Complete submission text file 0001628280-25-011830.txt   787015

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bvs-20250311.xsd EX-101.SCH 1785
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bvs-20250311_lab.xml EX-101.LAB 23449
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bvs-20250311_pre.xml EX-101.PRE 13584
17 EXTRACTED XBRL INSTANCE DOCUMENT bvs-20250311_htm.xml XML 3113
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 (919) 474-6700
Bioventus Inc. (Filer) CIK: 0001665988 (see all company filings)

EIN.: 810980861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37844 | Film No.: 25725873
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)